1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow MEDI2070: new trials by email Literature Review of MEDI2070 trials Research Report on MEDI2070
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease Brazikumab IV Infusion, Brazikumab SC Injection, Placebo - Crohn's Disease | Phase 2 | Terminated | AstraZeneca | 29 | 2016-01-05 | 2021-05-26 |
Crohn Disease (1) · Inflammatory Bowel Diseases (1)
AstraZeneca (1)
Australia (1) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Netherlands (1) · Russia (1) · Spain (1) · United States (1)
2015 (1)